Posts by: Alice Melão

Patients under Esbriet (pirfenidone) treatment for idiopathic pulmonary fibrosis (IPF) have a lower risk of hospitalization due to respiratory symptoms or respiratory complications, researchers reported. The findings were published in the American Journal of ... Read more

May 5, 2017May 5, 2017

Artificially Produced Cells Could Boost Lung Disease Research, Study Says

Idiopathic Pulmonary Fibrosis

Cells can be artificially produced that have many features of those found in human lung cells, researchers report. To do this, they identified the genetic program that regulates the formation ... Read more

April 28, 2017April 28, 2017

Phase 1 Interim Trial Results of miRagen’s Anti-Fibrotic Therapy Show Potential

Idiopathic Pulmonary Fibrosis, News

Initial results from a Phase 1 study on miRagen Therapeutics‘ investigative drug MRG-201 on healthy volunteers show potential for fibrous scar tissue in certain diseases. The company announced it will present ... Read more

April 27, 2017April 27, 2017

Experimental Drug RCM-1 May Have Therapeutic Potential to Block Inflammation and Mucus-Producing Cells Expansion

Asthma, News

Researchers from Cincinnati Children’s Hospital Medical Center found a new compound with therapeutic potential to block a protein called FOXM1, which is responsible for pro-inflammatory and hyper-mucous activity in asthma ... Read more